GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
This clinical trial will evaluate the safety, tolerability and efficacy of GLS-1027 in the
prevention of severe pneumonitis caused by SARS-CoV-2 infection